Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Spiro

Showing results (181-190 of 212) with videos related to

Pageof 22
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 5, 1998
Individualizing management of aggressive fibromatosesM A Spear, L C Jennings, H J Mankin, et al.
Plos Pathogens|October 24, 2009
Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellationsSarah M McDonald, Jelle Matthijnssens, John K McAllen, et al.
Cancer|December 20, 2011
Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomasJohn T Mullen, Wendy Kobayashi, Jing Jing Wang, et al.
Cancer|June 24, 2010
Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514William G Kraybill, Jonathan Harris, Ira J Spiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514William G Kraybill, Jonathon Harris, Ira J Spiro, et al.
Vaccine|September 13, 2017
Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccinesKathleen M Neuzil, Joseph S Bresee, Fernando de la Hoz, et al.
Science (New York, N.Y.)|October 5, 1973
Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndromeS Goldfischer, C L Moore, A B Johnson, et al.
Plos Pathogens|August 30, 2008
Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United StatesMartha I Nelson, Laurel Edelman, David J Spiro, et al.
Journal of Virology|June 26, 2009
Mixed infection and the genesis of influenza virus diversityElodie Ghedin, Adam Fitch, Alex Boyne, et al.
The American Journal of Tropical Medicine and Hygiene|November 4, 2011
Dual infection of novel influenza viruses A/H1N1 and A/H3N2 in a cluster of Cambodian patientsChristopher A Myers, Matthew R Kasper, Chadwick Y Yasuda, et al.
Pageof 22

Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
International Journal of Radiation Oncology, Biology, Physics|March 5, 1998
Individualizing management of aggressive fibromatosesM A Spear, L C Jennings, H J Mankin, et al.
Plos Pathogens|October 24, 2009
Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellationsSarah M McDonald, Jelle Matthijnssens, John K McAllen, et al.
Cancer|December 20, 2011
Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomasJohn T Mullen, Wendy Kobayashi, Jing Jing Wang, et al.
Cancer|June 24, 2010
Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514William G Kraybill, Jonathan Harris, Ira J Spiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514William G Kraybill, Jonathon Harris, Ira J Spiro, et al.
Vaccine|September 13, 2017
Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccinesKathleen M Neuzil, Joseph S Bresee, Fernando de la Hoz, et al.
Science (New York, N.Y.)|October 5, 1973
Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndromeS Goldfischer, C L Moore, A B Johnson, et al.
Plos Pathogens|August 30, 2008
Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United StatesMartha I Nelson, Laurel Edelman, David J Spiro, et al.
Journal of Virology|June 26, 2009
Mixed infection and the genesis of influenza virus diversityElodie Ghedin, Adam Fitch, Alex Boyne, et al.
The American Journal of Tropical Medicine and Hygiene|November 4, 2011
Dual infection of novel influenza viruses A/H1N1 and A/H3N2 in a cluster of Cambodian patientsChristopher A Myers, Matthew R Kasper, Chadwick Y Yasuda, et al.
Pageof 22